IRCT20200623047902N11尚未招募未知
Bioequivalence study of Sirolimus 1mg manufactured by Alborz Zagros company versus originator brand in healthy volunteers in fasting condition
Alborz Zagros company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to Sirolimus
研究者
相似试验
尚未招募
Unknown
Bioequivalence study of Sirolimus 1mg tabletIRCT20200623047902N35Zist takhmir company24
已完成
不适用
Clinical study on efficacy and safety of sirolimus against epileptic seizures of focal cortical dysplasia type IIPatients with epilepsy with focal cortical dysplasia type 2JPRN-UMIN000030962Hokkaido University Hospital2
进行中（未招募）
1 期
Prospective comparison of sirolimus against corticosteroids in treatment of patients with active thyroid eye diseaseThyroid eye diseaseCTIS2023-510166-27-01Helse Bergen HF70
进行中（未招募）
1 期
Sirolimus vs Corticosteroids in Treatment of Thyroid Eye DiseaseThyroid Eye Disease (TED) in patients with Graves' Diease.EUCTR2021-000641-41-NOHelse Bergen HF, Haukeland University Hospital70
已完成
3 期
Comparison of the Effects of Oral Sirolimus and Oral Cyclosporine on the Thrombocytopenic Chronic PurpuraImmune thrombocytopenic purpuraIRCT20180501039499N1Arak University of Medical Sciences60